Tag Archives: Alzheimer’s disease

Coalition Offers a Remedy for Stagnated Clinical Trials


Promising new clinical trial data offers fresh hope for the families of Alzheimer’s patients.  A new medication seems to be slowing the disease’s progress, limiting the cognitive decline that characterizes this “long goodbye.” Wouldn’t it be wonderful for patients suffering other diseases to have equally encouraging prospects? But many do not. Part of the problem lies with clinical trials.  For a new medication to receive FDA approval, it must undergo comprehensive testing on actual patients.  Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

CNN: Sandy’s Story

scientist, lab

CNN launched a new series profiling Sandy Halperin, a dentist and Harvard assistant professor, to raise awareness for the devastating impact of Alzheimer’s disease on a patient and his family. Producer Stephanie Smith describes Sandy’s Story as ‘an unprecedented look at the cruel journey of a vibrant, once healthy man as he gradually loses his memory.’ Halperin was diagnosed with early stage Alzheimer’s disease at age 60. The in-depth package explores the day-to-day reality of Read More >

Health, Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

The New Republic: We are Entering the Age of Alzheimer’s


The New Republic this week published a lengthy, powerful piece by Kent Russell on Alzheimer’s. Russell opens the piece by noting that we are approaching a public health crisis in Alzheimer’s and dementia: Alzheimer’s disease is practically unheard of in adults younger than 40, and very rare (one in 2,500) for those under 60. It affects 1 percent of 65-year-olds, 2 percent of 68-year-olds, 3 percent of 70-year-olds. After that, the odds start multiplying. The Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , ,

Greenwood Highlights Need for Bold Action to Address Alzheimer’s

Jim Greenwood

Last week, Jim Greenwood, President and CEO of the Biotechnology Industry Organization (BIO), participated and spoke at the #C4CT (Coalition for Concussion Treatment) Concussion Awareness Summit hosted at the United Nations in New York City. The day-long event explored links between Traumatic Brain Injury and Alzheimer’s Disease and featured leading policy experts, biotechnology entrepreneurs, academics,  investment firms, medical researchers, diplomats and professional athletes. The event was hosted by Brewer Sports International (BSI), a multi-faceted global Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

New Target for Alzheimer’s Disease


Biotechnologists have developed a drug candidate that blocks production of diseasecausing neurotoxins in mouse models Reducing the concentration of cathepsin B using an enzyme inhibitor prevents the creation of the neurotoxic peptide, pyroglutamate-AB (pGlu-AB), which has been linked to the development of Alzheimer’s disease (AD). The candidate inhibitor drug, a cysteine protease inhibitor named E64d, was developed by scientists from the University of California, San Diego School of Medicine, the Medical University of South Carolina and Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,